
Last update at 2026-06-22T19:57:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
| Breakdown |
|---|
| Breakdown |
|---|
| Breakdown |
|---|
Sector: None Industry: None
| Company | Change (CAD) | Price (CAD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| ABBV AbbVie CDR (CAD Hedged) |
1.80 5.94% | 32.11 | 84.53 | 13.62 | 5.74 | 50.90 | 6.95 | 24.11 |
| AVGO Broadcom CDR (CAD Hedged) |
-0.71 4.51% | 15.04 | 12.44 | 5.73 | 4.54 | 3.78 | 28.65 | 52.40 |
| WMT Walmart CDR (CAD Hedged) |
0.11 0.22% | 49.08 | 45.06 | 41.67 | 1.38 | 9.84 | 1.51 | 23.16 |
| LLY Eli Lilly CDR (CAD Hedged) |
0.26 0.66% | 39.62 | 37.91 | 25.77 | 12.03 | 29.35 | 12.92 | 26.57 |
| JPM JPMorgan CDR (CAD Hedged) |
0.54 1.29% | 42.50 | 14.46 | 14.03 | 4.49 | 2.36 | 6.97 |
| Name | Title | Year Born |
|---|---|---|
| Mr. Robert A. Michael CPA | CEO & Chairman of the Board | 1970 |
| Mr. Scott T. Reents | Executive VP & CFO | 1967 |
| Dr. Azita Saleki-Gerhardt Ph.D. | Executive VP & COO | 1963 |
| Mr. Jeffrey Ryan Stewart | Executive VP & Chief Commercial Officer | 1969 |
| Dr. Roopal Thakkar M.D. | Executive VP of Research and Development & Chief Scientific Officer | 1972 |
| Ms. Elizabeth Shea | Senior Vice President of Investor Relations | NA |
| Mr. Perry C. Siatis | Executive VP, General Counsel & Secretary | 1975 |
| Mr. Demetris D. Crum | Executive VP & Chief Human Resources Officer | NA |
| Mr. Wulff-Erik von Borcke | Senior VP & President of Oncology | NA |
| Dr. Nicholas J. Donoghoe M.D. | Executive VP and Chief Business & Strategy Officer | 1981 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.